A physiologically based pharmacokinetic model for methyl tert-butyl ether in humans: implementing sensitivity and...

Area of Science:

• Environmental Health
• Toxicology
• Pharmacokinetics

Background:

• Methyl tert-butyl ether (MTBE) is an gasoline additive used to reduce harmful emissions from vehicles.
• Understanding MTBE's behavior in the human body is crucial for assessing potential health risks.

Purpose of the Study:

• To validate a physiologically based pharmacokinetic (PBPK) model for predicting MTBE blood concentrations in humans.
• To examine how variations in MTBE metabolism affect predicted blood levels.

Main Methods:

• A flow-limited PBPK model with six compartments was developed for MTBE.
• Liver metabolism was modeled using Michaelis-Menten kinetics, with parameters derived from in vitro human liver microsome studies.
• Model predictions were compared against human blood MTBE data from controlled inhalation exposures.

Main Results:

• The PBPK model demonstrated high accuracy in predicting MTBE pharmacokinetics at low and high exposure levels.
• At intermediate concentrations, the model initially underpredicted MTBE blood levels but became accurate at later time points.
• Sensitivity and variability analyses revealed that metabolic parameters significantly impact model output, with greater variability observed in actual human blood levels than in model predictions.

Conclusions:

• The PBPK model, incorporating metabolic processes, effectively predicts MTBE blood levels in humans.
• This model is a valuable tool for estimating target tissue doses and informing risk assessments related to MTBE exposure.